BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34468949)

  • 41. Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules.
    Sahin M; Gursoy A; Tutuncu NB; Guvener DN
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):514-8. PubMed ID: 16984245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fine-needle aspiration in all thyroid incidentalomas at
    Trimboli P; Paone G; Treglia G; Virili C; Ruberto T; Ceriani L; Piccardo A; Giovanella L
    Clin Endocrinol (Oxf); 2018 Nov; 89(5):642-648. PubMed ID: 30019402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative dual isotope
    Benderradji H; Beron A; Wémeau JL; Carnaille B; Delcroix L; Do Cao C; Baillet C; Huglo D; Lion G; Boury S; Cussac JF; Caiazzo R; Pattou F; Leteurtre E; Vantyghem MC; Ladsous M
    Ann Endocrinol (Paris); 2021 Apr; 82(2):83-91. PubMed ID: 33727116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm?
    Muñoz Pérez N; Villar del Moral JM; Muros Fuentes MA; López de la Torre M; Arcelus Martínez JI; Becerra Massare P; Esteva Martínez D; Cañadas Garre M; Coll Del Rey E; Bueno Laraño P; Ferrón Orihuela JA
    Langenbecks Arch Surg; 2013 Jun; 398(5):709-16. PubMed ID: 23624819
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective evaluation of solitary thyroid nodule on 18F-FDG PET/CT and high-resolution ultrasonography.
    D'Souza MM; Marwaha RK; Sharma R; Jaimini A; Thomas S; Singh D; Jain M; Bhalla PJ; Tripathi M; Tiwari A; Mishra A; Mondal A; Tripathi RP
    Ann Nucl Med; 2010 Jun; 24(5):345-55. PubMed ID: 20373060
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prediction of Malignant Thyroid Nodules Using 18 F-FDG PET/CT-Based Radiomics Features in Thyroid Incidentalomas.
    Ko WS; Kim SJ
    Clin Nucl Med; 2023 Jun; 48(6):497-504. PubMed ID: 37001129
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm.
    Kim JM; Ryu JS; Kim TY; Kim WB; Kwon GY; Gong G; Moon DH; Kim SC; Hong SJ; Shong YK
    J Clin Endocrinol Metab; 2007 May; 92(5):1630-4. PubMed ID: 17284624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of
    Albano D; Gatta R; Marini M; Rodella C; Camoni L; Dondi F; Giubbini R; Bertagna F
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of malignancy in patients with cytologically suspicious thyroid nodules.
    Castro MR; Espiritu RP; Bahn RS; Henry MR; Gharib H; Caraballo PJ; Morris JC
    Thyroid; 2011 Nov; 21(11):1191-8. PubMed ID: 22007937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.
    Steward DL; Carty SE; Sippel RS; Yang SP; Sosa JA; Sipos JA; Figge JJ; Mandel S; Haugen BR; Burman KD; Baloch ZW; Lloyd RV; Seethala RR; Gooding WE; Chiosea SI; Gomes-Lima C; Ferris RL; Folek JM; Khawaja RA; Kundra P; Loh KS; Marshall CB; Mayson S; McCoy KL; Nga ME; Ngiam KY; Nikiforova MN; Poehls JL; Ringel MD; Yang H; Yip L; Nikiforov YE
    JAMA Oncol; 2019 Feb; 5(2):204-212. PubMed ID: 30419129
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Frequency of malignancy in thyroid incidentalomas detected by whole body 18F-FDG PET/CT].
    Ladrón de Guevara H D; Munizaga M C; García S N; Letelier B C; Wash F A
    Rev Med Chil; 2020 Jan; 148(1):10-16. PubMed ID: 32730431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidental Thyroid Nodules at Non-FDG PET Nuclear Medicine Imaging: Evaluation of Prevalence and Malignancy Rate.
    Yerubandi V; Chin BB; Sosa JA; Hoang JK
    AJR Am J Roentgenol; 2016 Feb; 206(2):420-5. PubMed ID: 26797373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Possible role of F18-FDG-PET/CT in differentiating benign lesions versus malignant after indeterminate fine-needle aspiration cytology. a wider and still controversial issue: exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis.
    Bertagna F; Giubbini R
    World J Surg; 2011 May; 35(5):1146-7; author reply 1148-9. PubMed ID: 21088836
    [No Abstract]   [Full Text] [Related]  

  • 54. The role of 18F-fluorodeoxyglucose positron emission tomography in thyroid neoplasms.
    Lang BH; Law TT
    Oncologist; 2011; 16(4):458-66. PubMed ID: 21378078
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer Risk Associated with Nuclear Atypia in Cytologically Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis.
    Valderrabano P; Khazai L; Thompson ZJ; Sharpe SC; Tarasova VD; Otto KJ; Hallanger-Johnson JE; Wadsworth JT; Wenig BM; Chung CH; Centeno BA; McIver B
    Thyroid; 2018 Feb; 28(2):210-219. PubMed ID: 29160163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Follow-Up or Surgery for Indeterminate Thyroid Nodules: Could the CUT Score Application Be a Support for Decision-Making in the Preoperative Assessment?
    Ianni F; Pascucci D; Paragliola RM; Rota CA; Perotti G; Fadda G; Pontecorvi A; Corsello SM
    Thyroid; 2020 Jan; 30(1):65-71. PubMed ID: 31552809
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of F-18 FDG-PET/CT and Tc-99m MIBI in the preoperative evaluation of cold thyroid nodules in the same patient group.
    Sager S; Vatankulu B; Erdogan E; Mut S; Teksoz S; Ozturk T; Sonmezoglu K; Kanmaz B
    Endocrine; 2015 Sep; 50(1):138-45. PubMed ID: 25795290
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
    Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?
    Kiernan CM; Solórzano CC
    J Am Coll Surg; 2017 Jul; 225(1):77-82. PubMed ID: 28223197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SUVmax of 18F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume.
    Kim TH; Ji YB; Song CM; Kim JY; Choi YY; Park JS; Tae K
    World J Surg Oncol; 2015 Jul; 13():217. PubMed ID: 26179774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.